Prokidney

ProKidney Corp. is a biotechnology company specializing in the development of cellular therapies for the treatment of chronic kidney disease (CKD). They make money by advancing their proprietary Renal Autologous Cell Therapy (REACT) platform, which aims to regenerate damaged kidney tissue and improve kidney function. Founded in 2015, ProKidney has made significant strides in clinical trials and has attracted substantial investment to support its innovative approach to CKD treatment. Their mission is to provide transformative therapies that address the unmet needs of CKD patients worldwide.

Recent Posts by Prokidney

1-20 of 162